127 related articles for article (PubMed ID: 1399148)
1. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells.
van den Brûle FA; Engel J; Stetler-Stevenson WG; Liu FT; Sobel ME; Castronovo V
Int J Cancer; 1992 Oct; 52(4):653-7. PubMed ID: 1399148
[TBL] [Abstract][Full Text] [Related]
2. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Castronovo V; Taraboletti G; Liotta LA; Sobel ME
J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
[TBL] [Abstract][Full Text] [Related]
3. Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins.
Shi YE; Torri J; Yieh L; Sobel ME; Yamada Y; Lippman ME; Dickson RB; Thompson EW
Clin Exp Metastasis; 1993 May; 11(3):251-61. PubMed ID: 8472397
[TBL] [Abstract][Full Text] [Related]
4. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
[TBL] [Abstract][Full Text] [Related]
6. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
Savoldi G; Ferrari F; Ruggeri G; Sobek L; Albertini A; Di Lorenzo D
Int J Biol Markers; 1995; 10(1):47-54. PubMed ID: 7629427
[TBL] [Abstract][Full Text] [Related]
7. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
Berkenstam A; Glaumann H; Martin M; Gustafsson JA; Norstedt G
Mol Endocrinol; 1989 Jan; 3(1):22-8. PubMed ID: 2915647
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin and steroid regulation of matrix metalloproteinases and their endogenous tissue inhibitors in the developed corpus luteum of the rhesus monkey during the menstrual cycle.
Young KA; Stouffer RL
Biol Reprod; 2004 Jan; 70(1):244-52. PubMed ID: 13679308
[TBL] [Abstract][Full Text] [Related]
10. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
Read LD; Snider CE; Miller JS; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
[TBL] [Abstract][Full Text] [Related]
11. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line.
Hurd C; Khattree N; Alban P; Nag K; Jhanwar SC; Dinda S; Moudgil VK
J Biol Chem; 1995 Dec; 270(48):28507-10. PubMed ID: 7499360
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
Dauvois S; Simard J; Dumont M; Haagensen DE; Labrie F
Mol Cell Endocrinol; 1990 Oct; 73(2-3):171-8. PubMed ID: 2269395
[TBL] [Abstract][Full Text] [Related]
13. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma.
Castronovo V; Campo E; van den Brûle FA; Claysmith AP; Cioce V; Liu FT; Fernandez PL; Sobel ME
J Natl Cancer Inst; 1992 Aug; 84(15):1161-9. PubMed ID: 1386115
[TBL] [Abstract][Full Text] [Related]
14. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
15. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
16. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
19. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
Berno V; Porrini D; Castiglioni F; Campiglio M; Casalini P; Pupa SM; Balsari A; Ménard S; Tagliabue E
Endocr Relat Cancer; 2005 Jun; 12(2):393-406. PubMed ID: 15947111
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells.
Pang H; Rowan BG; Al-Dhaheri M; Faber LE
Breast Cancer Res; 2004; 6(3):R239-45. PubMed ID: 15084247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
